INTO (Inhalation Together)
An alliance of three companies driven by expertise, knowledge,
and decades of inhalation industry experience.
As long-standing industry partners, the shifting tides of innovation and the growing importance of speed to market, combined with the complexities of inhaled formulation, encouraged us to unite our strengths and capabilities. Hence, a compelling conclusion arised: collaboration and synergy as key to success, providing a scientific and holistic solution-oriented approach to inhaled formulation development for small and large molecules.
In February 2022, the signing of an agreement marked INTO’s official journey, solidifying the commitment of all three companies involved — DFE Pharma GmbH & Co.KG, Harro Höfliger GmbH, and Sterling S.p.A. One shared vision, commitment to excellence, and the determination to accelerate DPI development is what unites us in the journey to come.
As we continue, we’re proud and excited about the possibilities ahead. INTO is more than just an alliance; it’s a shared passion of shaping the future of inhaled therapies.
Who we are
All 3 of our alliance partners are European-based companies, dealing with the landscape of highest regulatories (QbD, CQA, CPP). Summed up, they have over 100 yars of experience with well-established pharmaceutical companies worldwide.
As a leader in the field of Inhalation, DFE Pharma offers the pharmaceutical
industry the optimal solution for the development of their Dry Powder Inhaler (DPI) drug products.
DFE Pharma has been a partner for companies developing drugs for pulmonary delivery for many years, with a wide range of specialty inhalation grades of lactose and the option to customize to fit any formulation requirement. Our expertise and three dedicated inhalation production sites provide a unique starting point for any advanced pharmaceutical inhaled application.
Harro Höfliger is a German based company specialized in the development of customer-oriented process and production solutions for pharmaceutical and medical applications.
In the inhalation area, Harro Höfliger is providing the ideal dosing technology for filling powder into dry powder inhalers (DPI). Our processes are designed to manufacture blisters, capsules, disks, or reservoirs DPI closure systems. Harro Höfliger covers all phases from the laboratory stage to
high-performance production.
Sterling is a leading manufacturer of globally approved APIs with class leading facilities in Italy and Malta.
Sterling delivers cost-efficient synthesis, process development, solid state science, material characterisation, commercial manufacturing and life-cycle management solutions and has a proven capability to develop APIs for Respiratory sector used in pMDI, and complex DPI products. For more than 30 years Sterling has partnered with clients and supported successful complex inhalation programs providing advanced solutions for customers.
